LUCD CIK: 1799011

Lucid Diagnostics Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
57.3
FY22:
24.4
FY23:
22.1
FY24:
25.1
FY25:
37.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.70
FY22:
8.15
FY23:
5.20
FY24:
5.57
FY25:
2.98
Total assets
Change from FY21 to FY25
millions USD
FY21:
59.0
FY22:
32.5
FY23:
27.3
FY24:
30.7
FY25:
40.4

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.26
FY22:
8.43
FY23:
29.4
FY24:
23.5
FY25:
28.6
(negative)
millions USD
FY21:
0
FY22:
1.04
FY23:
0.20
FY24:
1.80
FY25:
0.93
(positive)
Change from FY21 to FY25
millions USD
FY21:
54.7
FY22:
23.0
FY23:
−2.31
FY24:
5.39
FY25:
10.9
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
59.0
FY22:
32.5
FY23:
27.3
FY24:
30.7
FY25:
40.4

All amounts in millions USD Data sources:SEC EDGARTwelve Data